2.52BMarket Cap-65.77P/E (TTM)
14.470High14.250Low16.74KVolume14.300Open14.300Pre Close241.24KTurnover0.02%Turnover Ratio24.12P/E (Static)174.31MShares21.92052wk High3.41P/B1.50BFloat Cap11.93452wk Low--Dividend TTM103.82MShs Float43.940Historical High--Div YieldTTM1.54%Amplitude7.390Historical Low14.411Avg Price1Lot Size
Hutchmed (China) Stock Forum
$Hutchmed (China) (HCM.US)$
$Intra-Cellular Therapies (ITCI.US)$ Phase 3
$CG Oncology (CGON.US)$ Phase 3
$Hutchmed (China) (HCM.US)$ Phase 3
$Viracta Therapeutics (VIRX.US)$ Phase 3
$GlycoMimetics (GLYC.US)$ Phase 3
$Annexon (ANNX.US)$ Phase 3
$Lipocine (LPCN.US)$ Phase 3
$FibroGen (FGEN.US)$ Phase 3
$UroGen Pharma Ltd (URGN.US)$ Phase 3
$Lyra Therapeutics (LYRA.US)$ Phase 3
$Citius Pharmaceuticals (CTXR.US)$ Phase 3
$Marinus Pharmaceuticals (MRNS.US)$ Phase 3
$BioCardia (BCDA.US)$ Phase 3 ...
According to the ac...
No comment yet